Amrita Krishnan

17.1k citations
198 papers · 5.6k · 2 hit papers · h-index 35

Impact in

  • Hematology top 0.2%
    • Multiple Myeloma Research and Treatments
    • Hematopoietic Stem Cell Transplantation
  • Oncology top 0.5%
    • CAR-T cell therapy research
    • Peptidase Inhibition and Analysis
    • Viral-associated cancers and disorders

Papers in

    • Multiple Myeloma Research and Treatments 115
    • Hematopoietic Stem Cell Transplantation 26
    • CAR-T cell therapy research 33
    • Viral-associated cancers and disorders 26

Amrita Krishnan

192 papers receiving 5.5k citations

Amrita Krishnan's Hit Papers

Talquetamab, a T-Cell–Redirecting GPRC5D Bispecific Antibody for Multiple Myeloma 2022 · 350 citations
3500+6+13Years since publication100200300400500

Peers

Amrita Krishnan
Comparison fields: 5 of 108
  • Hematology 2.9k
  • Oncology 2.8k
  • Genetics 745
  • Pathology and Forensic Medicine 1.1k
  • Virology 274
Replace Laurent Garderet with:
Laurent Garderet France
Peter Westervelt United States
Robert Vescio United States
Martin Gramatzki Germany
Georg Heß Germany
Matthias Theobald Germany
Patrick J. Stiff United States
Auayporn Nademanee United States
Graham Jackson United Kingdom
Ravi Vij United States
Amrita Krishnan relative to Laurent Garderet France Laurent Garderet's profile →
Citations per field
00.5×11×
Laurent Garderet · 1×
Citations per year

Countries citing papers authored by Amrita Krishnan

Since Specialization
Citations

This map shows the geographic impact of Amrita Krishnan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amrita Krishnan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amrita Krishnan more than expected).

Fields of papers citing papers by Amrita Krishnan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amrita Krishnan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amrita Krishnan. The network helps show where Amrita Krishnan may publish in the future.

Co-authors

The 25 scholars most cited alongside Amrita Krishnan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Amrita Krishnan Line = papers co-authored together Amrita Krishnan links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 198 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Multicenter Phase II Study of Bortezomib in Patients With Relapsed or Refractory Mantle Cell Lymphoma
Hit paper breakdown →
2006553
2 2009367
3
Talquetamab, a T-Cell–Redirecting GPRC5D Bispecific Antibody for Multiple Myeloma
Hit paper breakdown →
2022350
4 2017317
5 2010297
6 2001228
7 2000205
8
Treatment of severe veno-occlusive disease with defibrotide: compassionate use results in response without significant toxicity in a high-risk population.
1998187
9 2017149
10 2013129
11 2004119
12 2007113
13 201178
14 200676
15 200972
16 202065
17 202060
18 202053
19 200153
20 202048

About Amrita Krishnan

Amrita Krishnan is a scholar working on Hematology, Oncology, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Pathology and Forensic Medicine, having authored 198 papers that have together received 5.6k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (115 papers), Monoclonal and Polyclonal Antibodies Research (35 papers), Lymphoma Diagnosis and Treatment (34 papers), CAR-T cell therapy research (33 papers), Protein Degradation and Inhibitors (29 papers), Viral-associated cancers and disorders (26 papers), Hematopoietic Stem Cell Transplantation (26 papers) and Chronic Lymphocytic Leukemia Research (23 papers). The work is most often cited by research in Hematology (2.9k citations), Oncology (2.8k citations), Genetics (745 citations), Pathology and Forensic Medicine (1.1k citations) and Virology (274 citations). Amrita Krishnan has collaborated with scholars based in United States, Spain and Netherlands. Frequent co-authors include Stephen J. Forman, Sagar Lonial, Arturo Molina, Auayporn Nademanee, John A. Zaia, Ajai Chari, Henry C. Fung, Ricardo Spielberger, Paul G. Richardson and Edward A. Stadtmauer. Their work appears in journals such as Blood, Journal of Clinical Oncology, Biology of Blood and Marrow Transplantation, British Journal of Haematology and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact